Cepheid receives FDA clearance for Xpert Hemorrhagic Fever Panel

Cepheid, a Danaher operating company, announced the U.S. FDA cleared its Xpert Hemorrhagic Fever Panel. The test delivers results in approximately 61 minutes from a single sample to aid rapid diagnosis of patients with relevant symptoms.

Detected & updated continuously · Source: Nebula

Story subjects

CepheidDanaher CorporationU.S. Food and Drug Administration

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula